Phytochemicals and Their Possible Mechanisms in Managing COVID-19 and Diabetes

被引:4
作者
Sandoval-Gallegos, Eli Mireya [1 ]
Ramirez-Moreno, Esther [1 ]
Vargas-Mendoza, Nancy [2 ]
Arias-Rico, Jose [3 ]
Estrada-Luna, Diego [3 ]
Cuevas-Cancino, Jose Javier [3 ]
Jimenez-Sanchez, Reyna Cristina [3 ]
Flores-Chavez, Olga Rocio [3 ]
Baltazar-Tellez, Rosa Maria [3 ]
Morales-Gonzalez, Jose A. [2 ]
机构
[1] Univ Autonoma Estado Hidalgo, Area Acad Nutr, Ctr Invest Interdisciplinario, Inst Ciencias Salud, Circuito Ex Hacienda Concepc S-N, Carretera Pachuca 42160, San Agustin Tla, Mexico
[2] Inst Politecn Nacl Mexico Escuela Super Med, Lab Med Conservac Escuela Super Med, Plan San Luis Diaz Miron, Col Casco Santo Tomas,Alcaldia Miguel Hidalgo, Mexico City 11340, DF, Mexico
[3] Univ Autonoma Estado Hidalgo, Area Acad Enfermeria, Inst Ciencias Salud, Circuito Ex Hacienda Concepc S-N, Carretera Pachuca 42160, San Agustin Tla, Mexico
来源
APPLIED SCIENCES-BASEL | 2021年 / 11卷 / 17期
关键词
diabetes; SARS-CoV-2; COVID-19; curcumin; silymarin; sulforaphane; SILYMARIN; CURCUMIN; SARS-COV-2; BIOAVAILABILITY; SULFORAPHANE; CORONAVIRUS; CONSUMPTION; PREVENTION; DISORDER; NRF2;
D O I
10.3390/app11178163
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
For the writing of this manuscript, we searched information published from 2000 to 2021, through PubMed, Web of Science, Springer, and Science Direct. Focusing on the effects related to respiratory diseases, in addition to possible direct effects towards SARS-CoV-2, coupled with diabetes. Diabetes is a metabolic disease that is characterized by affecting the function of glucose, in addition to insulin insufficiency. This leads to patients with such pathologies as being at greater risk for developing multiple complications and increase exposure to viruses infections. This is the case of severe acute respiratory disease coronavirus 19 (SARS-CoV-2), which gave rise to coronavirus disease 2019 (COVID-19), declared an international public health emergency in March of 2020 Currently, several strategies have been applied in order to prevent the majority of the consequences of COVID-19, especially in patients with chronic diseases such as diabetes. Among the possible treatment options, we found that the use of phytochemical compounds has exhibited beneficial effects for the prevention and inhibition of infection by SARS-CoV-2, as well as for the improvement of the manifestations of diabetes.
引用
收藏
页数:13
相关论文
共 50 条
[31]   A physician's approach and experience of managing patients with diabetes during COVID-19 [J].
Ruslan, Aliya ;
Williams, David M. ;
Purnell, Oliver ;
Edwards, Rhodri ;
Peter, Raj ;
Stephens, Jeffrey W. ;
Chudleigh, Richard .
PRACTICAL DIABETES, 2021, 38 (02) :23-+
[32]   Managing IBD in the COVID-19 era [J].
Scalzo, Nicholas ;
Ungaro, Ryan C. .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
[33]   Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19 [J].
Olwal, Charles Ochieng' ;
Nganyewo, Nora Nghuchuzie ;
Tapela, Kesego ;
Djomkam Zune, Alexandra Lindsey ;
Owoicho, Oloche ;
Bediako, Yaw ;
Duodu, Samuel .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[34]   The impact of COVID-19 on people with diabetes in Brazil [J].
Ugliara Barone, Mark Thomaz ;
Harnik, Simone Bega ;
de Luca, Patricia Vieira ;
de Souza Lima, Bruna Leticia ;
Pineda Wieselberg, Ronaldo Jose ;
Ngongo, Belinda ;
Pedrosa, Hermelinda Cordeiro ;
Pimazoni-Netto, Augusto ;
Franco, Denise Reis ;
Marinho de Souza, Maria de Fatima ;
Malta, Deborah Carvalho ;
Giampaoli, Viviana .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 166
[35]   COVID-19 as a Trigger for Type 1 Diabetes [J].
Wang, Yichen ;
Guo, Hui ;
Wang, Gongquan ;
Zhai, Jiawei ;
Du, Bing .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (09) :2176-2183
[36]   Interactions between COVID-19 infection and diabetes [J].
Heshmati, Hassan M. .
FRONTIERS IN ENDOCRINOLOGY, 2024, 14
[37]   Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms [J].
Gonzalez Gonzalez, F. ;
Cortes Correa, C. ;
Penaranda Contreras, E. .
ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (04) :314-323
[38]   The patient with diabetes and COVID-19 [J].
Redondo Tebar, Andres ;
Postigo Mota, Salvador .
REVISTA ROL DE ENFERMERIA, 2021, 44 (01) :8-23
[39]   Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management [J].
Aslan, Anolin ;
Aslan, Cynthia ;
Zolbanin, Naime Majidi ;
Jafari, Reza .
PNEUMONIA, 2021, 13 (01)
[40]   COVID-19, Diabetes and Ramadan [J].
Tahseen A. Chowdhury ;
Salman Waqar ;
Sufyan Hussain ;
Syed H. Ahmed ;
Ateeq Syed ;
Ali Karamat ;
Ahmed Helmy ;
Nazim Ghouri .
Diabetes Therapy, 2020, 11 :2447-2451